Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age

European Journal of Clinical Pharmacology

Volumn 71, Issue 3, 2015, Pages 283-291

  Odsbu, Ingvild ^a   Skurtveit, Svetlana ^a,b   Selmer, Randi ^a   Roth, Christine ^c   Hernandez Diaz, Sonia ^d   Handal, Marte ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Lovisenberg Deacon Hospital   (Norway)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Anxiolytics; Hypnotics; Language competence; MoBa; Neurodevelopment; Pregnancy

Indexed keywords

ANALGESIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; FOLIC ACID; HYPNOTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRIPTAN DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ALCOHOL CONSUMPTION; ARTICLE; CHILD; DEPRESSION; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; GRAMMAR; HUMAN; LANGUAGE ABILITY; LANGUAGE DELAY; MARRIAGE; MATERNAL SMOKING; MULTIPLE PREGNANCY; NORMAL HUMAN; PARENTAL AGE; PASSIVE SMOKING; PATERNAL AGE; PREGNANCY; PREGNANT WOMAN; PRENATAL EXPOSURE; PRESCHOOL CHILD; PRIMIGRAVIDA; PRIORITY JOURNAL; SELF REPORT; UNPLANNED PREGNANCY; ADULT; CHEMICALLY INDUCED; LANGUAGE DEVELOPMENT; MALE; PROSPECTIVE STUDY; PSYCHOLOGY; YOUNG ADULT;

ADULT; ANTI-ANXIETY AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LANGUAGE DEVELOPMENT; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; SELF REPORT; YOUNG ADULT;

EID: 84925466841     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1797-4     Document Type: Article

References (29)

1. Facco FL, Kramer J, Ho KH, Zee PC, Grobman WA (2010) Sleep disturbances in pregnancy. Obstet Gynecol 115(1):77-83. doi: 10.1097/AOG.0b013e3181c4f8ec
2. Hedman C, Pohjasvaara T, Tolonen U, Suhonen-Malm AS, Myllyla VV (2002) Effects of pregnancy on mothers' sleep. Sleep Med 3(1):37-42
3. Hutchison BL, Stone PR, McCowan LM, Stewart AW, Thompson JM, Mitchell EA (2012) A postal survey of maternal sleep in late pregnancy. BMC Pregnancy Childbirth 12:144. doi: 10.1186/1471-2393-12-144
4. Pien GW, Schwab RJ (2004) Sleep disorders during pregnancy. Sleep 27(7):1405-1417
5. Sahota PK, Jain SS, Dhand R (2003) Sleep disorders in pregnancy. Curr Opin Pulm Med 9(6):477-483
6. Rubertsson C, Hellstrom J, Cross M, Sydsjo G (2014) Anxiety in early pregnancy: prevalence and contributing factors. Arch Womens Ment Health. doi: 10.1007/s00737-013-0409-0
7. Andersson L, Sundstrom-Poromaa I, Bixo M, Wulff M, Bondestam K, aStrom M (2003) Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. Am J Obstet Gynecol 189(1):148-154
8. Buhimschi CS, Weiner CP (2009) Medications in pregnancy and lactation: part 1. Teratol Obstet Gynecol 113(1):166-188. doi: 10.1097/AOG.0b013e31818d6788
9. Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K (2008) Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 65(5):653-660. doi: 10.1111/j.1365-2125.2008.03102.x
10. Gillberg C (1977) "Floppy infant syndrome" and maternal diazepam. Lancet 2(8031):244
11. McElhatton PR (1994) The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 8(6):461-475
12. Rementeria JL, Bhatt K (1977) Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 90(1):123-126
13. Laegreid L, Hagberg G, Lundberg A (1992) Neurodevelopment in late infancy after prenatal exposure to benzodiazepines - a prospective study. Neuropediatrics 23(2):60-67. doi: 10.1055/s-2008-1071314
14. Viggedal G, Hagberg BS, Laegreid L, Aronsson M (1993) Mental development in late infancy after prenatal exposure to benzodiazepines - a prospective study. J Child Psychol Psychiatr Allied Discip 34(3):295-305
15. Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, Stoltenberg C (2006) Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 35(5):1146-1150. doi: 10.1093/ije/dyl170
16. Irgens LM (2000) The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years. Acta Obstet Gynecol Scand 79(6):435-439
17. ATC Classification Index with DDDs (2013) WHO Collaborating Centre for Drug Statistics Methodology
18. Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M (2014) Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway. BJOG: Int J Obstet Gynaecol. doi: 10.1111/1471-0528.12821
19. Skurtveit S, Selmer R, Tverdal A, Furu K, Nystad W, Handal M (2013) Drug exposure: inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations. J Clin Epidemiol 66(9):964-972. doi: 10.1016/j.jclinepi.2013.02.011
20. Skurtveit S, Selmer R, Odsbu I, Handal M (2014) Self-reported data on medicine use in the Norwegian Mother and Child cohort study compared to data from the Norwegian Prescription Database
21. Dale PS, Price TS, Bishop DV, Plomin R (2003) Outcomes of early language delay: I. Predicting persistent and transient language difficulties at 3 and 4 years. J Speech Lang Hear Res 46(3):544-560
22. Roth C, Bjorke-Monsen AL, Reichborn-Kjennerud T, Nilsen RM, Smith GD, Stoltenberg C, Suren P, Susser E, Ueland PM, Vollset SE, Magnus P (2013) Use of folic acid supplements in early pregnancy in relation to maternal plasma levels in week 18 of pregnancy. Mol Nutr Food Res 57(4):653-660. doi: 10.1002/mnfr.201200116
23. Wikner BN, Stiller CO, Kallen B, Asker C (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: maternal characteristics. Pharmacoepidemiol Drug Saf 16(9):988-994. doi: 10.1002/pds.1391
24. Roth C, Magnus P, Schjolberg S, Stoltenberg C, Suren P, McKeague IW, Davey SG, Reichborn-Kjennerud T, Susser E (2011) Folic acid supplements in pregnancy and severe language delay in children. JAMA 306(14):1566-1573. doi: 10.1001/jama.2011.1433
25. Greenland S (1996) Basic methods for sensitivity analysis of biases. Int J Epidemiol 25(6):1107-1116
26. Riska BS, Skurtveit S, Furu K, Engeland A, Handal M (2014) Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. Eur J Clin Pharmacol 70(11):1367-1374. doi: 10.1007/s00228-014-1744-4
27. Nilsen RM, Vollset SE, Gjessing HK, Skjaerven R, Melve KK, Schreuder P, Alsaker ER, Haug K, Daltveit AK, Magnus P (2009) Self-selection and bias in a large prospective pregnancy cohort in Norway. Paediatr Perinat Epidemiol 23(6):597-608. doi: 10.1111/j.1365-3016.2009.01062.x
28. Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG (2012) Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006). Clin Ther 34(1):239-249.e232. doi: 10.1016/j.clinthera.2011.11.025
29. Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R (2004) Prescription drug use in pregnancy. Am J Obstet Gynecol 191(2):398-407. doi: 10.1016/j.ajog.2004.04.025